DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Organogenesis Holdings Q4 EPS $(0.04) Beats $(0.09) Estimate, Sales $74.6M Beat $70.41M Estimate

Organogenesis Holdings (NASDAQ:ORGO) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.09) by 55.56 percent. The company reported quarterly sales of $74.6 million which beat

Benzinga · 03/09/2020 20:07

Organogenesis Holdings (NASDAQ:ORGO) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.09) by 55.56 percent. The company reported quarterly sales of $74.6 million which beat the analyst consensus estimate of $70.41 million by 5.95 percent.